Diversity of penetration of anti-cancer agents into solid tumours

Area of Science:

• Pharmacology
• Oncology
• Drug Delivery

Background:

• Solid tumors exhibit resistance to anti-cancer agents due to incomplete drug penetration to clonogenic cells at cytotoxic concentrations.
• Understanding intratumor drug distribution is critical for overcoming this resistance mechanism.

Purpose of the Study:

• To evaluate the intratumor distribution of various anti-cancer agents in a solid tumor model.
• To classify these agents based on their distribution patterns in well-perfused versus poorly-perfused tumor regions.

Main Methods:

• Utilized a subcutaneously implanted mammary adenocarcinoma 16/C model in vivo.
• Assessed the intratumor distribution of five alkylating, bioreductive alkylating, and intercalating agents, plus two radiation sensitizers.
• Delineated tumor perfusion using lissamine green to define well- and poorly-perfused regions.

Main Results:

• Classified agents into three distribution patterns: proportional to vascular supply, uniform distribution, and preferential retention in poorly-perfused regions.
• Demonstrated that intratumor distribution patterns varied among the tested agents.
• Found no reliable method to predict an agent's distribution classification based on its chemical structure or mechanism of action.

Conclusions:

• Intratumor drug distribution is heterogeneous and agent-dependent.
• Current knowledge is insufficient to predict how different anti-cancer agents will distribute within solid tumors.
• Further research is needed to develop predictive models for drug distribution to improve anti-cancer therapy efficacy.